Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

High levels of the seizure medication sodium valproate can cause hair loss.

Agomelatine might help stop hair loss caused by valproate.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Serum ferritin is a better indicator than hemoglobin for detecting low iron in women with chronic hair loss.

Autoimmune diseases like lupus, dermatomyositis, and scleroderma can cause hair loss and other hair problems, and treatments for these diseases might also affect hair.

Lupus can cause a type of hair loss that doesn't scar, due to inflammation.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

A man with HIV had hair loss due to syphilis, which improved after penicillin treatment.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Certain growth factors affect hair loss in women and could be targeted for treatment.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.